Variant ID | 23322 |
---|---|
Entrez Gene ID | 157313 |
Gene | CDCA2 (GeneCards) |
Location | hg19 8:25524468-25524468
hg38 8:25666952-25666952 |
Disease | Asymptomatic |
Method | Single cell Sequencing Cell cloning |
Mutation(HGVS format) | NC_000008.10:g.25524468 C>T (Genome Assembly: GRCh37) |
Exon or Intron | NA |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 146364022 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | -0.5928 |
CADD Raw score (version 1.3) | -0.434251 (Deleterious) |
FATHMM raw prediction score | 0.05077 (Tolerated) |
Deleterious probability by DeFine | 0.2317 (Neutral) |
Entrez Gene ID | 157313 (NCBI Gene) |
---|---|
Official Gene Symbol | CDCA2 (GeneCards) |
Number of variants in CDCA2 in this database | 3 (view all the variants) |
Full name | cell division cycle associated 2 |
Band | 8p21.2 |
Other IDs | Vega: OTTHUMG00000099429 HGNC: HGNC:14623 Ensembl: ENSG00000184661 |
Other names | PPP1R81, Repo-Man |
Summary | This gene encodes a targeting subunit of the cell-cycle associated protein, protein phosphatase 1, with a role in targeting this protein to chromatin during anaphase. These two proteins comprise a phosphatase complex that is involved in nuclear envelope reformation and regulation of the DNA damage response. The encoded protein may also play a role in cancer progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015] |
Individual ID | 29217587.01 (view all the variants in this individual) |
---|---|
Pubmed ID | 29217587 |
Whose mosaic mutation | Normal |
Phenotype | 1 |
Disease | Asymptomatic |
OMIM ID |
Pubmed ID | 29217587 |
---|---|
Title | Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis. |
Journal | Science |
Publication date | 2018.02 |
Disease | Asymptomatic |
Number of cases | cases of unknown sex: 3; |